Anti-lfa-1 monoclonal antibodies used for the preparation of...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) C07K 16/28 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2154278

The medicament comprises as active ingredient at least a monoclonal antibody directed against the humain molecule LFA-1 in isotonic aqueous solution for perfusion and at least one stabilizing agent such as tris(hydroxymethyl)aminomethane and the Tween 380. For a solution of 1 litre, the medicament may comprise from 0.1 to 10 g, particularly approximately 1 g of monoclonal antibody, and from 0.1 to 10 g, particularly 2.4 g of tris(hydroxyméthyl)aminomethane or analogue and from 0.1 to 10, and particularly 2 per 10 thousand Tween 380.

Le médicament comprend à titre de principe actif au moins un anticorps monoclonal dirigé contre la molécule LFA-1 humaine en solution aqueuse isotonique pour perfusion et au moins un agent de stabilisation tel que le tris (hydroxyméthyle) aminométhane et le Tween ?80. Pour une solution d'un litre, médicament peut comprendre de 0,1 à 10 g, notamment 1 g environ d'anticorps monoclonal, et de 0,1 à 10 g, notamment 2,4 g de tris (hydroxyméthyle) aminométhane ou analogue et de 0,1 à 10, et notamment 2 pour dix mille de Tween ?80.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Anti-lfa-1 monoclonal antibodies used for the preparation of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-lfa-1 monoclonal antibodies used for the preparation of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-lfa-1 monoclonal antibodies used for the preparation of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1657551

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.